Literature DB >> 18039898

Equine multinodular pulmonary fibrosis: a newly recognized herpesvirus-associated fibrotic lung disease.

K J Williams1, R Maes, F Del Piero, A Lim, A Wise, D C Bolin, J Caswell, C Jackson, N E Robinson, F Derksen, M A Scott, B D Uhal, X Li, S A Youssef, S R Bolin.   

Abstract

Pulmonary fibrosis and interstitial lung disease are poorly understood in horses; the causes of such conditions are rarely identified. Equine herpesvirus 5 (EHV-5) is a gamma-herpesvirus of horses that has not been associated with disease in horses. Pathologic and virologic findings from 24 horses with progressive nodular fibrotic lung disease associated with EHV-5 infection are described and compared with 23 age-matched control animals. Gross lesions consisted of multiple nodules of fibrosis throughout the lungs. Histologically, there was marked interstitial fibrosis, often with preservation of an "alveolar-like" architecture, lined by cuboidal epithelial cells. The airways contained primarily neutrophils and macrophages. Rare macrophages contained large eosinophilic intranuclear viral inclusion bodies; similar inclusion bodies were also found cytologically. The inclusions were identified as herpesviral-like particles by transmission electron microscopy in a single horse. In situ hybridization was used to detect EHV-5 nucleic acids within occasional macrophage nuclei. With polymerase chain reaction (PCR), the herpesviral DNA polymerase gene was detected in 19/24 (79.2%) of affected horses and 2/23 (8.7%) of the control horses. Virus genera-specific PCR was used to detect EHV-5 in all of the affected horses and none of the control horses. EHV-2 was detected in 8/24 (33.3%) of affected horses and 1/9 (11.1%) of the control horses. This disease has not been reported before, and the authors propose that based upon the characteristic gross and histologic findings, the disease be known as equine multinodular pulmonary fibrosis. Further, we propose that this newly described disease develops in association with infection by the equine gamma-herpesvirus, EHV-5.

Entities:  

Mesh:

Year:  2007        PMID: 18039898     DOI: 10.1354/vp.44-6-849

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  33 in total

1.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

Review 2.  The Role of Aging in Idiopathic Pulmonary Fibrosis.

Authors:  Joseph Leung; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Lung       Date:  2015-04-23       Impact factor: 2.584

3.  Detection of Equid gammaherpesvirus 2 and 5 DNA in the upper respiratory tract of asymptomatic horses from Southern Brazil.

Authors:  Alais Maria Dall Agnol; Edsel Alves Beuttemmuller; Daniela Pilz; Raquel Arruda Leme; Viviane Saporiti; Selwyn Arlington Headley; Alice Fernandes Alfieri; Amauri Alcindo Alfieri
Journal:  Braz J Microbiol       Date:  2019-06-11       Impact factor: 2.476

Review 4.  Viral infection and aging as cofactors for the development of pulmonary fibrosis.

Authors:  Payal K Naik; Bethany B Moore
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

5.  Chronic interstitial pneumonia with features of organizing pneumonia in an adult horse.

Authors:  Miguel F Carrillo; Deborah Kemper; Leslie W Woods; Francisco R Carvallo
Journal:  J Vet Diagn Invest       Date:  2020-07       Impact factor: 1.279

6.  Age-dependent prevalence of equid herpesvirus 5 infection.

Authors:  Maria Luisa Marenzoni; Giacomo Coppola; Margherita Maranesi; Fabrizio Passamonti; Katia Cappelli; Stefano Capomaccio; Andrea Verini Supplizi; Etienne Thiry; Mauro Coletti
Journal:  Vet Res Commun       Date:  2010-09-15       Impact factor: 2.459

7.  Workshop on idiopathic pulmonary fibrosis in older adults.

Authors:  Richard J Castriotta; Basil A Eldadah; W Michael Foster; Jeffrey B Halter; William R Hazzard; James P Kiley; Talmadge E King; Frances McFarland Horne; Susan G Nayfield; Herbert Y Reynolds; Kenneth E Schmader; Galen B Toews; Kevin P High
Journal:  Chest       Date:  2010-09       Impact factor: 9.410

Review 8.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

Review 9.  Emerging concepts in the pathogenesis of lung fibrosis.

Authors:  William D Hardie; Stephan W Glasser; James S Hagood
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

10.  Development and Validation of a Quantitative PCR Method for Equid Herpesvirus-2 Diagnostics in Respiratory Fluids.

Authors:  Erika S Hue; Christine I Fortier; Aurélie M Laurent; Yann F Quesnelle; Guillaume D Fortier; Loïc J Legrand; Stephane L Pronost
Journal:  J Vis Exp       Date:  2016-03-17       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.